+10.2%
ORCL vs CME
+66.3%
-56.1%
-64.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CME | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -0.4% | +1.3% | +0.7% |
| 7D | -11.2% | +0.9% | -12.1% | -10.8% |
| 30D | -18.8% | +13.2% | -32.0% | -15.4% |
| 3M | -18.8% | +16.3% | -35.0% | -14.7% |
| 6M | -39.7% | +7.1% | -46.9% | -37.8% |
| YTD | -39.6% | +15.8% | -55.5% | -35.8% |
| 1Y | -51.7% | +17.1% | -68.8% | -48.4% |
| 3Y | +10.2% | +63.2% | -52.9% | +23.3% |
| All | +10.2% | +66.3% | -56.1% | +23.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CME.
Daily Out/Under-Performance
Portfolio return minus CME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling